We did however note increased GM-CSF+ CD4 T cells in patients on anti-TNF therapy, but even with the exclusion of these patients from the analysis, GM-CSF+ CD4 cells were still elevated in spondyloarthritis compared to controls (Supplementary Fig. 2B). This evidence concerns the gene TNF and spondyloarthropathy.